Krukowski, Karena; Ma, Jiachenga; Golonzhka, Olgab; Laumet, Geoffroy O.a; Gutti, Tanujaa; van Duzer, John H.b; Mazitschek, Ralphc; Jarpe, Matthew B.b; Heijnen, Cobi J.a; Kavelaars, Annemiekea,*
Author Information
aDepartment of Symptom Research, Laboratory of Neuroimmunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
bAcetylon Pharmaceuticals Inc, Boston, MA, USA
cCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA
*Corresponding author. Address: Department of Symptom Research, Laboratory of Neuroimmunology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 384, Houston, TX 77030, USA. Tel.: (713) 794-5297. E-mail address: [email protected] (A. Kavelaars).
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.painjournalonline.com).